Opioids, benzodiazepines, and COVID-19: A recipe for risk
J Hosp Med
.
2022 Jul;17(7):580-581.
doi: 10.1002/jhm.12889.
Epub 2022 Jun 14.
Authors
Koushik Kasanagottu
1
,
Shoshana J Herzig
1
Affiliation
1
Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Division of General Medicine, Boston, Massachusetts, USA.
PMID:
35700321
PMCID:
PMC9349968
DOI:
10.1002/jhm.12889
No abstract available
Publication types
Editorial
Comment
MeSH terms
Analgesics, Opioid / adverse effects
Benzodiazepines* / adverse effects
COVID-19*
Drug Therapy, Combination
Humans
Risk Factors
Substances
Analgesics, Opioid
Benzodiazepines
Grants and funding
R01 HS026215/HS/AHRQ HHS/United States
T32HP32715/HRSA/HRSA HHS/United States